IMNM
Price
$22.76
Change
-$0.32 (-1.39%)
Updated
Jul 31 closing price
Capitalization
2.58B
16 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$3.03
Change
-$0.10 (-3.19%)
Updated
Jul 31 closing price
Capitalization
183.08M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs VYGR

IMNM vs VYGR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMNM vs. VYGR commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (IMNM: $22.76 vs. VYGR: $3.03)
Brand notoriety: IMNM and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 29% vs. VYGR: 49%
Market capitalization -- IMNM: $2.58B vs. VYGR: $183.08M
IMNM [@Biotechnology] is valued at $2.58B. VYGR’s [@Biotechnology] market capitalization is $183.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMNM and VYGR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).

  • IMNM’s TA Score: 5 bullish, 5 bearish.
  • VYGR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than VYGR.

Price Growth

IMNM (@Biotechnology) experienced а +2.48% price change this week, while VYGR (@Biotechnology) price change was -2.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 19, 2026.

VYGR is expected to report earnings on Aug 03, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($2.58B) has a higher market cap than VYGR($183M). IMNM YTD gains are higher at: 5.959 vs. VYGR (-22.901). VYGR has higher annual earnings (EBITDA): -123.44M vs. IMNM (-235.83M). IMNM has more cash in the bank: 583M vs. VYGR (141M). IMNM has less debt than VYGR: IMNM (3.69M) vs VYGR (34.6M). VYGR has higher revenues than IMNM: VYGR (36.5M) vs IMNM (4.02M).
IMNMVYGRIMNM / VYGR
Capitalization2.58B183M1,409%
EBITDA-235.83M-123.44M191%
Gain YTD5.959-22.901-26%
P/E RatioN/A6.00-
Revenue4.02M36.5M11%
Total Cash583M141M413%
Total Debt3.69M34.6M11%
FUNDAMENTALS RATINGS
IMNM vs VYGR: Fundamental Ratings
IMNM
VYGR
OUTLOOK RATING
1..100
1162
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
4176
P/E GROWTH RATING
1..100
10010
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (54) in the Biotechnology industry is in the same range as IMNM (64) in the null industry. This means that VYGR’s stock grew similarly to IMNM’s over the last 12 months.

IMNM's Profit vs Risk Rating (84) in the null industry is in the same range as VYGR (100) in the Biotechnology industry. This means that IMNM’s stock grew similarly to VYGR’s over the last 12 months.

IMNM's SMR Rating (99) in the null industry is in the same range as VYGR (99) in the Biotechnology industry. This means that IMNM’s stock grew similarly to VYGR’s over the last 12 months.

IMNM's Price Growth Rating (41) in the null industry is somewhat better than the same rating for VYGR (76) in the Biotechnology industry. This means that IMNM’s stock grew somewhat faster than VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (10) in the Biotechnology industry is significantly better than the same rating for IMNM (100) in the null industry. This means that VYGR’s stock grew significantly faster than IMNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMNMVYGR
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PCMM49.840.03
+0.06%
BondBloxx Private Credit CLO ETF
HYFI37.09-0.01
-0.03%
AB High Yield ETF
HTRB33.10-0.11
-0.32%
Hartford Total Return Bond ETF
ORO17.97-0.15
-0.83%
Arrow Valtoro ETF
HRTS36.43-0.47
-1.26%
Tema Heart & Health ETF

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-1.39%
KYTX - IMNM
48%
Loosely correlated
-2.54%
KURA - IMNM
48%
Loosely correlated
-3.22%
NRIX - IMNM
46%
Loosely correlated
-1.57%
VYGR - IMNM
44%
Loosely correlated
-3.19%
RLAY - IMNM
44%
Loosely correlated
-3.19%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with EDIT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-3.19%
EDIT - VYGR
54%
Loosely correlated
-4.09%
CLDX - VYGR
48%
Loosely correlated
-1.10%
KURA - VYGR
48%
Loosely correlated
-3.22%
RXRX - VYGR
46%
Loosely correlated
-1.32%
CRBU - VYGR
45%
Loosely correlated
-3.31%
More